UVA Health: Trial Identifies Better Treatment for Grade 2 Gliomas
December 04, 2024
December 04, 2024
CHARLOTTESVILLE, Virginia, Dec. 4 -- University of Virginia Health issued the following news release:
Adding the chemotherapy pill temozolomide to radiation treatment significantly improves survival for adults with brain tumors known as grade 2 gliomas, a clinical trial led by a top UVA Health cancer expert has found.
The randomized, phase 3 trial followed 172 patients for more than 10 years, comparing outcomes for those who received radiation alone versus those who rec . . .
Adding the chemotherapy pill temozolomide to radiation treatment significantly improves survival for adults with brain tumors known as grade 2 gliomas, a clinical trial led by a top UVA Health cancer expert has found.
The randomized, phase 3 trial followed 172 patients for more than 10 years, comparing outcomes for those who received radiation alone versus those who rec . . .